Quidel® Corporation is committed to enhancing health and well-being through innovative diagnostic solutions. Quidel assays use lateral-flow, direct fluorescent antibody, molecular and other technologies to improve patient outcomes and give economic benefits to healthcare providers. With leading brands - QuickVue®, AmpliVue®, Lyra®, MicroVue™, D3® Direct Detection, Thyretain®, Sofia®, and Solana®, Quidel aids in the detection and diagnosis of critical diseases and conditions. www.quidel.com